 CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.In light of the advances made, "Science" magazine hailed cancer immunotherapy as its 2013 Breakthrough of the Year.Agenus (formerly Antigenics Inc.) was founded in 1994 by Garo H. Armen and Pramod K. Srivastava.